These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12827705)

  • 1. The four R's: reactive/repair, reporting, and regulations.
    Moriarty AT; Young NA
    Diagn Cytopathol; 2003 Jul; 29(1):1-3. PubMed ID: 12827705
    [No Abstract]   [Full Text] [Related]  

  • 2. The 1988 Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. Developed and approved at a National Cancer Institute Workshop, Bethesda, Maryland, U.S.A., December 12-13, 1988.
    J Reprod Med; 1989 Oct; 34(10):779-85. PubMed ID: 2677354
    [No Abstract]   [Full Text] [Related]  

  • 3. Internal quality assurance of sensitivity of primary screening.
    Boxer ME
    Cytopathology; 1998 Oct; 9(5):349-50. PubMed ID: 9800134
    [No Abstract]   [Full Text] [Related]  

  • 4. [An operative model: verification of the quality of the screening Pap test ].
    Montanari GR; Arnaud S; Berardengo E; Campione D; Cozzani C; Parisio F; Viberti L; Ghiringhello B
    Pathologica; 2001 Oct; 93(5):609-10. PubMed ID: 11725370
    [No Abstract]   [Full Text] [Related]  

  • 5. American Society for Cytotechnology quality assurance survey data. Summary report.
    Ashton PR
    Acta Cytol; 1989; 33(4):451-4. PubMed ID: 2750434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for reducing Papanicolaou smear screening errors: principles derived from data and experience with quality control.
    Krieger PA
    Arch Pathol Lab Med; 1997 Mar; 121(3):277-81. PubMed ID: 9111118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMOs should stress quality tests in light of pap smear controversy.
    Johnson DE
    Contract Healthc; 1988 Feb; ():27. PubMed ID: 10318142
    [No Abstract]   [Full Text] [Related]  

  • 8. The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop.
    J Reprod Med; 1992 May; 37(5):383-6. PubMed ID: 1354748
    [No Abstract]   [Full Text] [Related]  

  • 9. Redefinition and categorization of "Pap test" reporting.
    McGregor JA
    J Reprod Med; 1990 May; 35(5):541-2. PubMed ID: 2352249
    [No Abstract]   [Full Text] [Related]  

  • 10. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991.
    Acta Cytol; 1993; 37(2):115-24. PubMed ID: 8465628
    [No Abstract]   [Full Text] [Related]  

  • 11. Harvard HMO improves Pap smear screening.
    Herman R
    QA Rev; 1989 Oct; 1(3):2-3. PubMed ID: 10318359
    [No Abstract]   [Full Text] [Related]  

  • 12. [Maryland--Greece--Finland?].
    Mäkinen J
    Duodecim; 1999; 115(22):2506-7. PubMed ID: 11973975
    [No Abstract]   [Full Text] [Related]  

  • 13. Forum on criteria for certification, licensure and quality control of cytology laboratories.
    Acta Cytol; 1971; 15(6):562-76. PubMed ID: 4944870
    [No Abstract]   [Full Text] [Related]  

  • 14. Opinion poll on quality assurance and quality control. Conducted by the Committee on Continuing Education and Quality Assurance of the International Academy of Cytology.
    Vooijs GP
    Acta Cytol; 1996; 40(1):14-24. PubMed ID: 8604568
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid pre-screening: a validated quality assurance measure in cervical cytology.
    Smith J; Nicholas D; Boyd K; Deacon-Smith R
    Cytopathology; 2003 Oct; 14(5):275-80. PubMed ID: 14510892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCI makes changes in the Bethesda System.
    Am Fam Physician; 1992 Sep; 46(3):967-8. PubMed ID: 1514480
    [No Abstract]   [Full Text] [Related]  

  • 17. When MTs mind the Paps: QA for send-out tests.
    Cruzvergara M
    MLO Med Lab Obs; 1991 Feb; 23(2):31-5. PubMed ID: 10109603
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving the benchmark. Makers of a better, more costly Pap test face a tough sell.
    Hensley S
    Mod Healthc; 1997 May; 27(19):52. PubMed ID: 10173014
    [No Abstract]   [Full Text] [Related]  

  • 19. Personal performance profiles: a useful adjunct to quality assurance in cervical cytology.
    Houliston DC; Boyd CM; Nicholas DS; Smith JA
    Cytopathology; 1998 Jun; 9(3):162-70. PubMed ID: 9638377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [External quality control in cervical cytopathology: an evaluation from 2000-2004].
    Rev Saude Publica; 2007 Dec; 41(6):1071. PubMed ID: 18066478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.